Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Amphastar Pharmaceuticals (AMPH) over the last 4 years, with Q4 2016 value amounting to $46.1 million.

  • Amphastar Pharmaceuticals' Shares Outstanding (Weighted Average) rose 226.02% to $46.1 million in Q4 2016 from the same period last year, while for Dec 2016 it was $46.1 million, marking a year-over-year increase of 226.02%. This contributed to the annual value of $46.1 million for FY2016, which is 226.02% up from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Shares Outstanding (Weighted Average) stood at $46.1 million for Q4 2016, which was up 226.02% from $45.4 million recorded in Q3 2016.
  • Amphastar Pharmaceuticals' Shares Outstanding (Weighted Average)'s 5-year high stood at $46.1 million during Q4 2016, with a 5-year trough of $38769.0 in Q1 2014.
  • For the 4-year period, Amphastar Pharmaceuticals' Shares Outstanding (Weighted Average) averaged around $34.6 million, with its median value being $44.6 million (2015).
  • Per our database at Business Quant, Amphastar Pharmaceuticals' Shares Outstanding (Weighted Average) tumbled by 9989.73% in 2014 and then soared by 11494294.67% in 2015.
  • Amphastar Pharmaceuticals' Shares Outstanding (Weighted Average) (Quarter) stood at $38.7 million in 2013, then rose by 8.38% to $42.0 million in 2014, then grew by 7.46% to $45.1 million in 2015, then grew by 2.26% to $46.1 million in 2016.
  • Its last three reported values are $46.1 million in Q4 2016, $45.4 million for Q3 2016, and $45.0 million during Q2 2016.